Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.

MLA

Matossian, Margarite D., et al. “Application of a Small Molecule Inhibitor Screen Approach to Identify CXCR4 Downstream Signaling Pathways That Promote a Mesenchymal and Fulvestrant-Resistant Phenotype in Breast Cancer Cells.” Oncology Letters, vol. 21, no. 5, May 2021, p. N.PAG. EBSCOhost, https://doi.org/10.3892/ol.2021.12641.

APA

Matossian, M. D., Elliott, S., Rhodes, L. V., Martin, E. C., Hoang, V. T., Burks, H. E., Zuercher, W. J., Drewry, D. H., Collins-Burow, B. M., & Burow, M. E. (2021). Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells. Oncology Letters, 21(5), N.PAG. https://doi.org/10.3892/ol.2021.12641

Chicago

Matossian, Margarite D., Steven Elliott, Lyndsay V. Rhodes, Elizabeth C. Martin, Van T. Hoang, Hope E. Burks, William J. Zuercher, David H. Drewry, Bridgette M. Collins-Burow, and Matthew E. Burow. 2021. “Application of a Small Molecule Inhibitor Screen Approach to Identify CXCR4 Downstream Signaling Pathways That Promote a Mesenchymal and Fulvestrant-Resistant Phenotype in Breast Cancer Cells.” Oncology Letters 21 (5): N.PAG. doi:10.3892/ol.2021.12641.